SCHEMBL3264240

SCHEMBL3264240

COc1ccc(CC(=O)O)cc1Oc1ccc(N(C(=O)C(C)(C)C)c2ccccc2)cc1C[S+]([O-])C(C)(C)C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.45
FABP4 P15090 2/20 0.38
GAA P10253 3/20 0.38
NPSR1 Q6W5P4 1/20 0.38
TSHR P16473 2/20 0.38
ALDH1A1 P00352 1/20 0.38
NFKB1 P19838 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
CA5A P35218 1/20 0.37
PTGDR2 Q9Y5Y4 6/20 0.37
POLB P06746 1/20 0.35
SELL P14151 1/20 0.35
SELP P16109 1/20 0.35
TBXA2R P21731 1/20 0.35
PTGDR Q13258 1/20 0.35
CYP1A2 P05177 1/20 0.34
CYP2C19 P33261 1/20 0.34
KMT2A Q03164 1/20 0.34
BCHE P06276 1/20 0.34
ACHE P22303 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1570963 0.85 CYP3A4 (0.63) CYP3A4FABP4GAANPSR1TSHR
SCHEMBL2280449 0.79 PTGDR2 (0.48) CYP3A4PTGDR2TBXA2RPTGDR
SCHEMBL349853 0.79 CYP3A4 (0.70) CYP3A4FABP4GAANPSR1TSHR
SCHEMBL13521953 0.76 CYP3A4 (0.49) CYP3A4GAANPSR1TSHRALDH1A1
SCHEMBL12197418 0.74 PTGDR2 (0.46) CYP3A4GAATSHRALDH1A1NFKB1
Benzene SCHEMBL2280257 0.71 PTGDR2 (0.46) CYP3A4GAANPSR1TSHRALDH1A1
SCHEMBL21328360 0.71 GAA (0.70) CYP3A4GAANPSR1TSHRALDH1A1
SCHEMBL2280248 0.71 CHRM1 (0.46) CYP3A4GAANPSR1TSHRALDH1A1
SCHEMBL2285931 0.70 PTGDR2 (0.50) CYP3A4GAANPSR1PTGDR2TBXA2R
SCHEMBL19033464 0.70 CYP3A4 (0.63) CYP3A4GAANPSR1TSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010003127-A2 ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS AMIRA PHARMACEUTICALS, INC. (US) 2010-01-07 WO disclosed